Weissbach G, Domula M, Lenk H
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(3):345-66.
Disturbances of haemostasis caused immunologically and non-immunologically were observed after transfusion of blood and blood derivatives. Transfusion of heparin blood increased the bleeding susceptibility only in case of pre-existing high-degree defects of haemostasis or if they were performed as massive or exchange transfusions. Massive transfusions with blood stored for a long time will induce complex defects. Under intensive substitution therapy of haemophilia A the so-called paradoxical bleeding will occur in spite of a high factor VIII level. These bleedings are supposed to be disturbances of the thrombocyte function and are caused by fibrin(ogen) derivatives. Post-transfusional thrombocytopenias may be brought to remission by repeated plasmapheresis. Factor specific inhibitory bodies will appear after substitution in a small percentage of haemophilic patients. 5 to 7 days after the onset of therapy an anamnestic reaction can be observed as a titre increase by leaps. Usually, the inhibitory titre will decrease to a mostly low basal value in the course of three to five months. The therapy with cyclophosphamide simultaneously started with the substitution will more frequently prevent the anamnestic reaction or reduce it. Titres with more than 5 units cannot be overcome at the beginning even by higher concentrations of preparations. The substitution therapy should be preceded by exchange transfusions or plasmapheresis of up to 25 units. With still higher titres only procedures of inhibitor-bypassing are possible with factor VIII preparations of animal origin or better with activated prothrombin complex preparations, such as FEIBA. Recent reports give evidence that permanent substitution with factor VIII concentrates at a highest dosage can eliminate the production of inhibitors completely.
输血及血液制品后可观察到免疫性和非免疫性引起的止血障碍。输注肝素血仅在已有高度止血缺陷或进行大量输血或换血时才会增加出血易感性。大量输注保存时间长的血液会导致复杂的缺陷。在对甲型血友病进行强化替代治疗时,尽管因子VIII水平很高,仍会发生所谓的矛盾性出血。这些出血被认为是血小板功能障碍,由纤维蛋白(原)衍生物引起。输血后血小板减少症可通过反复血浆置换得到缓解。一小部分血友病患者在替代治疗后会出现因子特异性抑制性抗体。治疗开始5至7天后,可观察到回忆反应,表现为滴度急剧上升。通常,抑制滴度在三到五个月内会降至大多较低的基础值。与替代治疗同时开始的环磷酰胺治疗更常能预防或减轻回忆反应。即使使用更高浓度的制剂,开始时也无法克服滴度超过5单位的情况。替代治疗前应进行多达25单位的换血或血浆置换。对于更高的滴度,只能使用动物源性因子VIII制剂或更好地使用活化凝血酶原复合物制剂(如FEIBA)进行旁路抑制剂治疗。最近的报告表明,以最高剂量持续使用因子VIII浓缩物进行替代治疗可完全消除抑制剂的产生。